Second-generation antidepressant drugs
4.7 (674) · $ 20.50 · In stock
Download Table | Second-generation antidepressant drugs from publication: Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force | Depression among youth is a disabling condition that is associated with serious long-term morbidities and suicide. To assess the health effects of routine primary care screening for major depressive disorder among children and adolescents aged 7 to 18 years. Medline, the | Mass Screening, Major Depressive Disorder and Adolescents | ResearchGate, the professional network for scientists.
Comparative efficacy and acceptability of 21 antidepressant drugs
Treatments for Mood Disorders - ppt download
Impact of evergreening on patients and health insurance: a meta
Second-generation antidepressant drugs
Neuropathic Antidepressant Medications
Chirality of Modern Antidepressants: An Overview. - Abstract
Treatment-induced mood switching in affective disorders
Depressive and Bipolar Disorders - ppt download
Second-generation antidepressant drugs
Introduction - Screening for Child and Adolescent Depression In
Frontiers Antioxidant Activity of Fluoxetine and Vortioxetine in
Mood switch in bipolar depression: comparison of adjunctive